
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.600 | 0.610 | 0.010 |
Bonds | 99.390 | 99.390 | 0.000 |
Convertible | 0.010 | 0.010 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.926 | 15.774 |
Price to Book | 1.493 | 2.292 |
Price to Sales | 0.274 | 1.519 |
Price to Cash Flow | 2.980 | 7.344 |
Dividend Yield | - | 3.798 |
5 Years Earnings Growth | - | 10.199 |
Name | Net % | Category Average |
---|---|---|
Corporate | 79.831 | 39.143 |
Government | 13.756 | 23.236 |
Securitized | 5.755 | 32.686 |
Cash | 0.596 | 11.931 |
Municipal | 0.052 | 0.418 |
Number of long holdings: 2,092
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
United States Treasury Notes | - | 1.38 | - | - | |
United States Treasury Notes | - | 1.22 | - | - | |
United States Treasury Notes | - | 1.05 | - | - | |
United States Treasury Notes | - | 0.71 | - | - | |
AbbVie Inc. | - | 0.61 | - | - | |
The Boeing Company | - | 0.59 | - | - | |
United States Treasury Notes | - | 0.56 | - | - | |
Pfizer Investment Enterprises Pte Ltd. | - | 0.55 | - | - | |
United States Treasury Notes | - | 0.52 | - | - | |
United States Treasury Notes | - | 0.50 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Bond Market II Index | 179.56B | 6.10 | 4.91 | 1.80 | ||
Vanguard Total Bond Market II Idx I | 159.04B | 6.05 | 4.84 | 1.73 | ||
Vanguard Target Retire Trust Plus35 | 136.72B | 14.72 | 17.34 | 9.64 | ||
The Vanguard Target Retire 2035 Tr1 | 136.72B | 14.72 | 17.34 | 9.63 | ||
The Vanguard Target Retire 2035 Tr2 | 136.72B | 14.71 | 17.32 | 9.62 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review